ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

5 links0 made here, not in the record6 judgments1 judge (the rules as one: Rule based)2 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07750990An Extension Study ofS-606001 in ParticipantsWith Late-onset PompeDisease (LOPD)ShionogiPhase 2 · not yet recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSGlycogen Storage Disease Ty…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionRare DiseasesThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseGlycogen Storage DiseaseThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedDRUGSS-606001Intervention entry›As of now · Rule based · TestedTestedElosulfase alfaEntry “ERT”, read by our name rule›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Glycogen Storage Disease Type II

From the registry record2 judgments on this link
Kind of condition link, from the registry to what was judged
RegistryGlycogen Storage Disease Type II, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Nov 14Glycogen Storage Disease Type IIRule based · condition-kind ruleFinest filed termCurrent
Nov 14Rare DiseasesRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
Nov 14Glycogen Storage DiseaseRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowGlycogen Storage Disease Type IIRule based · main-condition ruleMain conditionCurrent
As of nowS-606001Rule based · role ruleTestedCurrent
As of nowElosulfase alfaRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.